Crawford & Company
NYSE: CRD-B · FINANCIAL SERVICES · INSURANCE BROKERS
Updated 2026-04-30
Crawford & Company (CRD-B) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for CRD-B.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
CRD-B historical valuation range
Where current P/E sits in CRD-B's own 5Y range.
CRD-B intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
CRD-B valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 25.49x
P/S Ratio — History
Current: 0.39x
Is CRD-B overvalued in 2026?
Crawford & Company (CRD-B) currently trades at $10.03 per share with a market capitalization of $486,967,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 55/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 25.5x, above its 5-year median of 20.9x. The PEG ratio of 0.90 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, CRD-B is currently trading more expensive than 70% of the last 5Y on P/E. This places it in the 70th percentile of its historical range, a reasonable but unremarkable position.
A standard DCF model does not produce reliable output for CRD-B under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
Financial quality is a concern. The Piotroski F-Score of 2/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: CRD-B trades at a fair valuation on our framework, with a Smart Value Score of 55/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is CRD-B overvalued in 2026?
Based on a Smart Value Score of 55/100, CRD-B is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is CRD-B's fair value?
Standard DCF is unreliable for CRD-B due to its current profitability profile. Revenue-based approaches such as EV/Sales or historical P/S percentile are more informative for this stock.
What P/E ratio does CRD-B trade at?
CRD-B trades at a P/E of 25.5x on trailing twelve-month earnings, compared to its 5-year median of 20.9x.
Is CRD-B a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 55/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does CRD-B's valuation compare to its history?
On P/E, CRD-B currently sits in the 70th percentile of its own 5Y range. That is above its long-run median relative to where it has traded over the period.
What is CRD-B's Smart Value Score?
CRD-B's Smart Value Score is 55/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.